Hematopoietic reprogramming reflects the selective and evolutionarily conserved engagement of transcription factor networks that encode innate immune memory in long-lived stem cells.
The increasing knowledge of barrier tissue-resident memory macrophages and trained innate immunity (TII) will help develop both nontarget-specific and target-specific TII-based vaccine strategies.
Prestigious peer-review validates HCB101's differentiated mechanism and translational strength. Clinical data show a nearly ...
Respiratory infections represent a significant burden across veterinary medicine, impacting companion animals, livestock, poultry, and wildlife species.
The preclinical drug from Vanqua Bio is designed to inhibit “C5aR1,” a part of the immune system that regulates inflammation.
Light Chain Bioscience, a clinical-stage biotechnology company advancing the next generation of bispecific antibodies to treat cancer, today presented positive results from a Phase 1/1b study of ...
Presentations highlight HCB101's differentiated profile and introduce first preclinical data from HCB301, underscoring HanchorBio's innovation in ...
Company completes first tranche of a $7 million financing to increase cash runway and maintain Nasdaq complianceSOUTH SAN FRANCISCO, Calif., Oct.
The oral C5aR1 antagonist is designed to modulate neutrophil-driven inflammation, a central mechanism underlying many inflammatory ...
A study published in Nature looks at COVID-19 mRNA vaccines and the immune response to tumours during immunotherapy. Prof Andrew Beggs, MRC Senior Clinical Fellow and Consultant Colorectal Surgeon, ...
The poster for INSIGHT-003 and the Trial in Progress ePoster for TACTI-004 can be found at the Posters & Publications section of Immutep’s website.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback